# Einstein-Rockefeller-CUNY Center for AIDS Research

> **NIH NIH P30** · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2021 · $2,792,128

## Abstract

PROJECT SUMMARY
 As the AIDS research community and public health systems locally, nationally and globally focus efforts
on preventing HIV transmission and ending the epidemic, it is critical to integrate our efforts across institutions
and disciplines, sharing resources among many researchers to achieve the greatest gain in scientific
understanding. In the current absence of a CFAR in New York, an epicenter of HIV infection, our strategic
planning process made clear that the greatest contribution of a New York City-based CFAR would be achieved
by reaching out to other institutions. Thus, the Einstein/Rockefeller/CUNY (ERC)-CFAR has created a highly
synergistic new partnership of non-overlapping complementary resources, linking a strong basic and clinical
research institution (Einstein)`with a large patient base, a globally pre-eminent basic science institution
(Rockefeller), and a strong public health/implementation science institution (CUNY) to catalyze research to
prevent HIV and end the epidemic. We are structured to collaborate extensively across disciplines and
institutions to drive a trans-institutional, interdisciplinary, and coordinated research agenda by ERC-CFAR
investigators focused on “bench to bedside to community and back to the bench” research, and translating
science into reality by assessing implementation of strategies and treatments shown to be efficacious in clinical
and bench research. The ERC-CFAR will stimulate, coordinate, and support an integrated multidisciplinary
research agenda to achieve our mission, to arrest the AIDS epidemic, through improving utilization of current
treatments and developing new therapies, such as potent broadly neutralizing antibodies, for prevention,
reducing the incidence of new infections; treatment, improving treatment outcomes among infected individuals;
and eradication of HIV reservoirs. The ERC-CFAR will develop new research aimed at ending the epidemic by
implementing five Specific Aims: 1) To empower a proactive, inclusive, and integrated program leadership
approach to drive a trans-institutional, interdisciplinary, and coordinated research agenda by ERC-CFAR
investigators focused on “bench to bedside to community and back to the bench” research to reduce HIV
incidence, improve access to treatment, promote adherence, improve outcomes and eradicate HIV reservoirs
to arrest the AIDS epidemic; 2) To utilize three Scientific Cores to support and advance the basic, clinical,
behavioral, epidemiological, translational, and implementation research of the ERC-CFAR investigators; 3) To
provide the intellectual, technical, and financial support to advance the careers of the next generation of young,
innovative, and interdisciplinary HIV/AIDS investigators, while recruiting established investigators into
HIV/AIDS research and forging new collaborations across institutions; 4) To build an innovative community
partnership with representatives from government, community, and academia, to participate i...

## Key facts

- **NIH application ID:** 10147756
- **Project number:** 5P30AI124414-06
- **Recipient organization:** ALBERT EINSTEIN COLLEGE OF MEDICINE
- **Principal Investigator:** HARRIS GOLDSTEIN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $2,792,128
- **Award type:** 5
- **Project period:** 2017-05-01 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10147756

## Citation

> US National Institutes of Health, RePORTER application 10147756, Einstein-Rockefeller-CUNY Center for AIDS Research (5P30AI124414-06). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10147756. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*